Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Konin – page 2

45 clinical trials in Konin, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Konin at a glance
45
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

45 trials in Konin

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Camizestrant
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merus B.V.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Macrogenics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Macrogenics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Celcuity Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:BioNTech SE
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Inhibrx Biosciences Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Immutep
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Pfizer Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Konin

What the registry says about research in the country

01 Lung Cancer Research

Innovative clinical trials exploring treatments for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), including studies of novel immunotherapy combinations and targeted therapies.

  • Advanced/metastatic NSCLC treatments
  • Extensive-stage SCLC therapies
  • Immunotherapy combinations

Multiple studies evaluating new drug combinations to improve survival rates and treatment outcomes.

02 Breast Cancer Innovations

Research focusing on hormone receptor-positive, HER2-negative breast cancer, investigating novel therapeutic approaches and combination treatments.

  • Advanced/metastatic breast cancer
  • Targeted therapy combinations
  • Hormone therapy resistance

Studies examining new treatment options for patients with advanced breast cancer, particularly those who have progressed after prior therapies.

03 Gastrointestinal Oncology

Clinical trials investigating treatments for colorectal cancer and gastric cancer, including studies of targeted therapies and immunotherapy approaches.

  • HER2-expressing gastric cancer
  • BRAF-mutant colorectal cancer
  • Combination therapy approaches

Research focused on improving treatment outcomes through targeted therapeutic strategies and novel drug combinations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.